Amphastar Pharmaceuticals, Inc. (AMPH) SEC Filings — 2024
17 SEC filings for Amphastar Pharmaceuticals, Inc. (AMPH) in 2024.
Filings
- Amphastar Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Amphastar Pharmaceuticals Files 8-K on Financials — 8-K · Nov 6, 2024
- Amphastar Pharma Secures $150M Loan Facility — 8-K · Aug 30, 2024
- Amphastar Pharmaceuticals Q2 2024 10-Q Filing — 10-Q · Aug 9, 2024
- Amphastar Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2024
- Amphastar Pharmaceuticals Appoints New CFO — 8-K · Jun 4, 2024
- Amphastar Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Amphastar Pharmaceuticals Files 8-K — 8-K · May 8, 2024
- Amphastar Pharmaceuticals Files Definitive Proxy Statement — DEFA14A · Apr 19, 2024
- Amphastar Pharmaceuticals Files Definitive Proxy Statement — DEFA14A · Apr 12, 2024
- Amphastar Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Mar 6, 2024
- Amphastar Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- Amphastar Pharma Files 8-K on Financial Condition — 8-K · Feb 28, 2024
- Amphastar Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Amphastar Insider Jack Zhang Updates Holdings; Maintains Significant Stake — SC 13G/A · Feb 9, 2024
- BlackRock Amends Amphastar Pharma Stake (SC 13G/A) — SC 13G/A · Jan 23, 2024
- Federated Hermes Amends Amphastar Pharma Stake as of Dec 31, 2023 — SC 13G/A · Jan 17, 2024